Innate Pharma S.A. ADR (IPHA)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Results
download Want to compare other data? Select Fields| Symbol | IPHA | MENS | PRQR | ||
| Company | Innate Pharma S.A. ADR | Jyong Biotech Ltd | Proqr Therapeutics | ||
| Price Information | |||||
| Exchange | NASDAQ | NASDAQ | NASDAQ | ||
| Open | 1.7000 | 1.97 | 1.4300 | ||
| High | 1.7050 | 2.10 | 1.4800 | ||
| Low | 1.5700 | 1.88 | 1.4200 | ||
| Latest | 1.6200 | 2.01 | 1.4400 | ||
| Change | -0.0700 | +0.02 | -0.0300 | ||
| % Change | -4.14% | +1.01% | -2.04% | ||
| Volume | 29,900 | 187,200 | 249,600 | ||
| 20-Day Average Volume | 21,110 | 400,725 | 402,410 | ||
| Previous Close | 1.6900 | 1.99 | 1.4700 | ||
| Industry | Medical - Biomedical | Medical - Biomedical | Medical - Biomedical | ||
| Has Options | No | No | Yes | ||
| Technicals | |||||
| 20-Day Moving Average | 1.7422 | 2.11 | 1.5340 | ||
| 20-Day Raw Stochastic | 15.62% | 33.53% | 23.66% | ||
| 20-Day Relative Strength | 40.28 | 29.24 | 37.65 | ||
| Weighted Alpha | -29.46 | -60.90 | -53.26 | ||
| Today's Opinion | 100% Sell | N/A | 88% Sell | ||
| Previous Opinion | 100% Sell | N/A | 88% Sell | ||
| Last Month's Opinion | 100% Sell | N/A | 72% Sell | ||
| Performance | |||||
| 5-Days | |||||
| %Chg | -2.41% since 02/12/26 | +36.73% since 02/12/26 | +3.60% since 02/12/26 | ||
| Low | 1.5700 on 02/20/26 | 1.45 on 02/13/26 | 1.4100 on 02/13/26 | ||
| High | 1.8633 on 02/13/26 | 2.26 on 02/18/26 | 1.5799 on 02/18/26 | ||
| 1-Month | |||||
| %Chg | -10.50% since 01/20/26 | -38.34% since 01/20/26 | -14.29% since 01/20/26 | ||
| Low | 1.5700 on 02/20/26 | 1.43 on 02/11/26 | 1.3300 on 02/12/26 | ||
| High | 1.8900 on 01/30/26 | 3.40 on 01/21/26 | 1.7950 on 01/23/26 | ||
| 3-Month | |||||
| %Chg | -10.99% since 11/20/25 | -93.87% since 11/20/25 | -30.10% since 11/20/25 | ||
| Low | 1.5700 on 02/20/26 | 1.43 on 02/11/26 | 1.3300 on 02/12/26 | ||
| High | 2.0100 on 12/01/25 | 38.88 on 11/25/25 | 2.4850 on 12/16/25 | ||
| 6-Month | |||||
| %Chg | -27.35% since 08/20/25 | -95.78% since 08/20/25 | -32.71% since 08/20/25 | ||
| Low | 1.5700 on 02/20/26 | 1.43 on 02/11/26 | 1.3300 on 02/12/26 | ||
| High | 2.4250 on 11/10/25 | 67.00 on 09/19/25 | 3.1000 on 10/21/25 | ||
| Key Statistics | |||||
| Market Capitalization, $K | 151,857 | 152,816 | 151,507 | ||
| Shares Outstanding, K | 93,739 | 76,028 | 105,213 | ||
| Annual Sales | 21,770,000 | 0 | 20,460,000 | ||
| Annual Net Income | -53,530,000 | -3,019,000 | -30,040,000 | ||
| Last Quarter Sales | N/A | N/A | 3,370,000 | ||
| Last Quarter Net Income | N/A | N/A | -12,860,000 | ||
| 60-Month Beta | -0.02 | N/A | 0.20 | ||
| Per-Share Information | |||||
| Most Recent Earnings | N/A | N/A | -0.12 on 11/06/25 | ||
| Latest Earnings Date | 03/26/26 | N/A | 03/12/26 | ||
| Most Recent Dividend | N/A | N/A | N/A | ||
| Next Ex-Dividends Date | N/A | N/A | N/A | ||
| Ratios | |||||
| Price/Earnings ttm | 0.00 | 0.00 | 0.00 | ||